Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet. 2024;404:1991–2005.

Article  PubMed  Google Scholar 

Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, et al. Treatment and clinical outcome of clinical T4 esophageal cancer: a systematic review. Ann Gastroenterol Surg. 2019;3:169–80.

Article  PubMed  Google Scholar 

Miyata H, Sugimura K, Motoori M, Omori T, Yamamoto K, Yanagimoto Y, et al. Clinical implications of conversion surgery after induction therapy for T4b thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:4737–43.

Article  PubMed  Google Scholar 

Tsuji T, Matsuda S, Sato Y, Tanaka K, Sasaki K, Watanabe M, et al. Safety and efficacy of conversion therapy after systemic chemotherapy in advanced esophageal cancer with distant metastases: a multicenter retrospective observational study. Ann Surg Oncol. 2025;32:274–83.

Article  PubMed  Google Scholar 

Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–21.

Article  CAS  PubMed  Google Scholar 

Jingu K, Umezawa R, Matsushita H, Sugawara T, Kubozono M, Yamamoto T, et al. Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan. Int J Clin Oncol. 2016;21:276–82.

Article  CAS  PubMed  Google Scholar 

Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol. 2004;34:615–9.

Article  PubMed  Google Scholar 

Miyazaki T, Sohda M, Tanaka N, Suzuki S, Ieta K, Sakai M, et al. Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer. Cancer Chemother Pharmacol. 2015;75:449–55.

Article  CAS  PubMed  Google Scholar 

Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, et al. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 2015;106:407–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugawara K, Yagi K, Okumura Y, Nishida M, Aikou S, Yamashita H, et al. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma. Int J Clin Oncol. 2020;25:552–60.

Article  CAS  PubMed  Google Scholar 

Sugawara K, Mori K, Yagi K, Aikou S, Uemura Y, Yamashita H, et al. Association of preoperative inflammation-based prognostic score with survival in patients undergoing salvage esophagectomy. Dis Esophagus. 2019. https://doi.org/10.1093/dote/doy066.

Article  PubMed  Google Scholar 

Ohkura Y, Ueno M, Iizuka T, Udagawa H. Prognostic factors and appropriate lymph node dissection in salvage esophagectomy for locally advanced T4 esophageal cancer. Ann Surg Oncol. 2019;26:209–16.

Article  PubMed  Google Scholar 

Booka E, Haneda R, Ishii K, Kawakami T, Tsushima T, Yasui H, et al. Appropriate candidates for salvage esophagectomy of initially unresectable locally advanced T4 esophageal squamous cell carcinoma. Ann Surg Oncol. 2020;27:3163–70.

Article  PubMed  Google Scholar 

Okamura A, Hayami M, Kozuki R, Takahashi K, Toihata T, Imamura Y, et al. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma. Esophagus. 2020;17:59–66.

Article  PubMed  Google Scholar 

Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, et al. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer. Br J Cancer. 2016;115:1328–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugimura K, Miyata H, Tanaka K, Makino T, Takeno A, Shiraishi O, et al. Multicenter randomized phase 2 trial comparing chemoradiotherapy and docetaxel plus 5-fluorouracil and cisplatin chemotherapy as initial induction therapy for subsequent conversion surgery in patients with clinical T4b esophageal cancer: short-term results. Ann Surg. 2021;274: e465–e72.

Article  Google Scholar 

Yamasaki M, Miyata H, Yamashita K, Hamakawa T, Tanaka K, Sugimura K, et al. Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized phase 2 trial. Br J Cancer. 2023;129:54–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan WL, Choi CW, Wong IY, Tsang TH, Lam AT, Tse RP, et al. Docetaxel, cisplatin, and 5-FU triplet therapy as conversion therapy for locoregionally advanced unresectable esophageal squamous cell carcinoma. Ann Surg Oncol. 2023;30:861–70.

Article  PubMed  Google Scholar 

Shimoji H, Karimata H, Nagahama M, Nishimaki T. Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study. World J Surg. 2013;37:2180–8.

Article  PubMed  Google Scholar 

Karimata H, Shimoji H, Nishimaki T. Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy. Surg Today. 2015;45:479–86.

Article  CAS  PubMed  Google Scholar 

Sugawara K, Yagi K, Uemura Y, Okumura Y, Nishida M, Aikou S, et al. Associations of systemic inflammation and sarcopenia with survival of esophageal carcinoma patients. Ann Thorac Surg. 2020;110:374–82.

Article  PubMed  Google Scholar 

Sugawara K, Yagi K, Okumura Y, Aikou S, Yamashita H, Seto Y. Survival prediction capabilities of preoperative inflammatory and nutritional status in esophageal squamous cell carcinoma patients. World J Surg. 2022;46:639–47.

Article  PubMed  Google Scholar 

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Ide S, Kitajima T, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg. 2020;272:342–51.

Article  PubMed  Google Scholar 

Ishibashi Y, Tsujimoto H, Hiraki S, Kumano I, Yaguchi Y, Horiguchi H, et al. Prognostic value of preoperative systemic immunoinflammatory measures in patients with esophageal cancer. Ann Surg Oncol. 2018;25:3288–99.

Article  PubMed  Google Scholar 

Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Takahashi K, et al. The impact of pretherapeutic Naples prognostic score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09549-5.

Article  PubMed  Google Scholar 

Daiko H, Kato K. Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer. Jpn J Clin Oncol. 2020;50:847–51.

Article  PubMed  Google Scholar 

Teranishi R, Makino T, Tanaka K, Yamashita K, Saito T, Yamamoto K, et al. Long-term survival and prognostic factors associated with curative conversion surgery for CT4b esophageal squamous cell carcinoma: analysis of 200 consecutive cases. Surgery. 2023;174:558–66.

Article  PubMed  Google Scholar 

Yamashita H, Haga A, Takenaka R, Kiritoshi T, Okuma K, Ohtomo K, et al. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer. Radiat Oncol. 2016;11:4.

Article  PubMed  PubMed Central  Google Scholar 

Mine S, Tanaka K, Kawachi H, Shirakawa Y, Kitagawa Y, Toh Y, et al. Japanese classification of esophageal cancer, 12th edition: part I. Esophagus. 2024;21:179–215.

Article  PubMed  PubMed Central  Google Scholar 

Doki Y, Tanaka K, Kawachi H, Shirakawa Y, Kitagawa Y, Toh Y, et al. Japanese classification of esophageal cancer, 12th edition: part II. Esophagus. 2024;21:216–69.

Article  PubMed  PubMed Central  Google Scholar 

Yamamoto T, Takahashi A, Yoshizumi T, Ishihara S, Inomata M, Imoto S, et al. 2023 National Clinical Database Annual Report by the Japan Surgical Society. Surg Today. 2025;55:295–334.

Article  PubMed  PubMed Central  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Su